- Report
- February 2024
- 250 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- October 2023
- 177 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2022
- 129 Pages
Global
From €5721EUR$5,950USD£4,908GBP
- Report
- March 2022
Global
From €4663EUR$4,850USD£4,001GBP
- Report
- March 2020
Japan, United States, ... Japan, United States, Europe
From €1394EUR$1,450USD£1,196GBP
- Book
- August 2019
- 416 Pages
Cholinesterase is an enzyme that plays an important role in the nervous system. It is responsible for breaking down the neurotransmitter acetylcholine, which is involved in muscle contraction, memory, and learning. Cholinesterase inhibitors are used to treat a variety of neurological disorders, including Alzheimer's disease, myasthenia gravis, and glaucoma.
The cholinesterase market is a rapidly growing segment of the enzyme industry. It is driven by the increasing prevalence of neurological disorders, as well as the development of new treatments. Companies in the market are focused on developing and manufacturing cholinesterase inhibitors, as well as providing services related to their use.
Some of the major companies in the cholinesterase market include Merck, Pfizer, Novartis, and GlaxoSmithKline. Other companies include AbbVie, AstraZeneca, and Johnson & Johnson. Show Less Read more